Regulators raise an eyebrow at GSK lung disease drug efficacy
Expert reviewers at the FDA have cast doubt over the effectiveness of a drug GlaxoSmithKline said could be used to treat patients with COPD.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Chronic Obstructive Pulmonary | Pharmaceuticals